Reducing Uncertainty in Within-Host Parameter Estimates of Influenza Infection by Measuring Both Infectious and Total Viral Load

For in vivo studies of influenza dynamics where within-host measurements are fit with a mathematical model, infectivity assays (e.g. 50% tissue culture infectious dose; TCID50) are often used to estimate the infectious virion concentration over time. Less frequently, measurements of the total (infectious and non-infectious) viral particle concentration (obtained using real-time reverse transcription-polymerase chain reaction; rRT-PCR) have been used as an alternative to infectivity assays. We investigated the degree to which measuring both infectious (via TCID50) and total (via rRT-PCR) viral load allows within-host model parameters to be estimated with greater consistency and reduced uncertainty, compared with fitting to TCID50 data alone. We applied our models to viral load data from an experimental ferret infection study. Best-fit parameter estimates for the “dual-measurement” model are similar to those from the TCID50-only model, with greater consistency in best-fit estimates across different experiments, as well as reduced uncertainty in some parameter estimates. Our results also highlight how variation in TCID50 assay sensitivity and calibration may hinder model interpretation, as some parameter estimates systematically vary with known uncontrolled variations in the assay. Our techniques may aid in drawing stronger quantitative inferences from in vivo studies of influenza virus dynamics.

[1]  A. Perelson,et al.  HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.

[2]  A. Perelson,et al.  Influenza A virus infection kinetics: quantitative data and models , 2011, Wiley interdisciplinary reviews. Systems biology and medicine.

[3]  A. Perelson.  Modelling viral and immune system dynamics , 2002, Nature Reviews Immunology.

[4]  H. Klenk,et al.  Human influenza A viruses are proteolytically activated and do not induce apoptosis in CACO-2 cells. , 2003, Virology.

[5]  Udo Reichl,et al.  Mathematical model of influenza A virus production in large-scale microcarrier culture. , 2005, Biotechnology and bioengineering.

[6]  F. J. Miller,et al.  Upper respiratory tract surface areas and volumes of laboratory animals and humans: considerations for dosimetry models. , 1997, Journal of toxicology and environmental health.

[7]  Alan S. Perelson,et al.  Modeling Within-Host Dynamics of Influenza Virus Infection Including Immune Responses , 2012, PLoS Comput. Biol..

[8]  C. Beauchemin,et al.  Exploring Cell Tropism as a Possible Contributor to Influenza Infection Severity , 2010, PloS one.

[9]  Alan S. Perelson,et al.  Quantifying the Early Immune Response and Adaptive Immune Response Kinetics in Mice Infected with Influenza A Virus , 2010, Journal of Virology.

[10]  Dr. Frans W. Orthel.  Influenza virus titrations and the inhibitor of hemagglutination in normal allantoic fluid , 2005, Archiv für die gesamte Virusforschung.

[11]  P. I. Marcus,et al.  Dynamics of Biologically Active Subpopulations of Influenza Virus: Plaque-Forming, Noninfectious Cell-Killing, and Defective Interfering Particles , 2009, Journal of Virology.

[12]  A. García-Sastre,et al.  Influenza A viruses: new research developments , 2011, Nature Reviews Microbiology.

[13]  Michael P. Busch,et al.  High Specific Infectivity of Plasma Virus from the Pre-Ramp-Up and Ramp-Up Stages of Acute Simian Immunodeficiency Virus Infection , 2009, Journal of Virology.

[14]  L. Zhang,et al.  Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement , 2003, Journal of Clinical Virology.

[15]  Iain Stephenson,et al.  Reproducibility of serology assays for pandemic influenza H1N1: collaborative study to evaluate a candidate WHO International Standard. , 2012, Vaccine.

[16]  Ann Cullinane,et al.  Dynamics of Influenza Virus Infection and Pathology , 2010, Journal of Virology.

[17]  C. Beauchemin,et al.  Design considerations in building in silico equivalents of common experimental influenza virus assays , 2011, Autoimmunity.

[18]  G. Fischer,et al.  A clinical specimen collection and transport medium for molecular diagnostic and genomic applications , 2010, Epidemiology and Infection.

[19]  A. L. Lloyd,et al.  The dependence of viral parameter estimates on the assumed viral life cycle: limitations of studies of viral load data , 2001, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[20]  C. Beauchemin,et al.  Neuraminidase inhibitors for treatment of human and avian strain influenza: A comparative modeling study. , 2011, Journal of theoretical biology.

[21]  Ruy M Ribeiro,et al.  Modeling the viral dynamics of influenza A virus infection. , 2010, Critical reviews in immunology.

[22]  Robert B. Schnabel,et al.  Computational experience with confidence intervals for nonlinear least squares , 1986 .

[23]  T. Shimada,et al.  Titration of hepatitis B virus infectivity in the sera of pre‐acute and late acute phases of HBV infection: Transmission experiments to chimeric mice with human liver repopulated hepatocytes , 2008, Journal of medical virology.

[24]  Andreas Handel,et al.  Neuraminidase Inhibitor Resistance in Influenza: Assessing the Danger of Its Generation and Spread , 2007, PLoS Comput. Biol..

[25]  Alan S. Perelson,et al.  Effect of 1918 PB1-F2 Expression on Influenza A Virus Infection Kinetics , 2011, PLoS Comput. Biol..

[26]  C. Beauchemin,et al.  Quantification system for the viral dynamics of a highly pathogenic simian/human immunodeficiency virus based on an in vitro experiment and a mathematical model , 2012, Retrovirology.

[27]  A. Nomoto,et al.  Total viral genome copies and virus-Ig complexes after infection with influenza virus in the nasal secretions of immunized mice. , 2004, The Journal of general virology.

[28]  E. Biscaia,et al.  Nonlinear parameter estimation through particle swarm optimization , 2008 .

[29]  Alan S. Perelson,et al.  Viral Dynamics during Primary Simian Immunodeficiency Virus Infection: Effect of Time-Dependent Virus Infectivity , 2010, Journal of Virology.

[30]  Guy Boivin,et al.  The H275Y Neuraminidase Mutation of the Pandemic A/H1N1 Influenza Virus Lengthens the Eclipse Phase and Reduces Viral Output of Infected Cells, Potentially Compromising Fitness in Ferrets , 2012, Journal of Virology.

[31]  A H Rowberg,et al.  Influenza virus population dynamics in the respiratory tract of experimentally infected mice , 1976, Infection and immunity.

[32]  Andreas Handel,et al.  A review of mathematical models of influenza A infections within a host or cell culture: lessons learned and challenges ahead , 2011, BMC public health.

[33]  A. Perelson,et al.  Simulation and Prediction of the Adaptive Immune Response to Influenza A Virus Infection , 2009, Journal of Virology.

[34]  G. Wennemuth,et al.  Release of Macrophage Migration Inhibitory Factor and CXCL8/Interleukin-8 from Lung Epithelial Cells Rendered Necrotic by Influenza A Virus Infection , 2002, Journal of Virology.

[35]  U Reichl,et al.  Infection dynamics and virus-induced apoptosis in cell culture-based influenza vaccine production-Flow cytometry and mathematical modeling. , 2009, Vaccine.

[36]  Guy Boivin,et al.  Assessing the In Vitro Fitness of an Oseltamivir-Resistant Seasonal A/H1N1 Influenza Strain Using a Mathematical Model , 2011, PloS one.

[37]  E. Walsh,et al.  Comparison of Quantitative Reverse Transcription-PCR to Viral Culture for Assessment of Respiratory Syncytial Virus Shedding , 2003, Journal of Clinical Microbiology.

[38]  Frederick R Adler,et al.  An accurate two-phase approximate solution to an acute viral infection model , 2010, Journal of mathematical biology.

[39]  F. Horsfall.  On the reproduction of influenza virus; quantitative studies with procedures which enumerate infective and hemagglutinating virus particles. , 1954 .

[40]  T. F. Smith,et al.  Replication and plaque assay of influenza virus in an established line of canine kidney cells. , 1968, Applied microbiology.

[41]  Andreas Handel,et al.  Towards a quantitative understanding of the within-host dynamics of influenza A infections , 2010, Journal of The Royal Society Interface.

[42]  I. Hewlett,et al.  Stability and infectivity of novel pandemic influenza A (H1N1) virus in blood-derived matrices under different storage conditions , 2011, BMC infectious diseases.

[43]  N. Dimmock,et al.  Defective interfering viruses and their potential as antiviral agents , 2010, Reviews in medical virology.

[44]  A. Perelson,et al.  Kinetics of Influenza A Virus Infection in Humans , 2006, Journal of Virology.

[45]  Ruy M Ribeiro,et al.  Modeling amantadine treatment of influenza A virus in vitro. , 2008, Journal of theoretical biology.

[46]  H. Ginsberg.  FORMATION OF NON-INFECTIOUS INFLUENZA VIRUS IN MOUSE LUNGS: ITS DEPENDENCE UPON EXTENSIVE PULMONARY CONSOLIDATION INITIATED BY THE VIRAL INOCULUM , 1954, The Journal of experimental medicine.

[47]  C. Beauchemin,et al.  Exploring the effect of biological delays in kinetic models of influenza within a host or cell culture , 2011, BMC public health.